Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Schraml

Showing results (1-10 of 113) with videos related to

Pageof 12
Sort By:
International Journal of Cancer|March 7, 2016
PD-L1 expression is regulated by hypoxia inducible factor in clear cell renal cell carcinomaMelanie Ruf, Holger Moch, Peter Schraml
Oncoimmunology|November 21, 2015
Interaction of tumor cells with infiltrating lymphocytes via CD70 and CD27 in clear cell renal cell carcinomaMelanie Ruf, Holger Moch, Peter Schraml
Histopathology|December 20, 2018
Clear cell renal cell carcinoma with wild-type von Hippel-Lindau gene: a non-existent or new tumour entity?Aashil A Batavia, Peter Schraml, Holger Moch
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 20, 2021
Cytoplasmic ADP-ribosylation levels correlate with markers of patient outcome in distinct human cancersFabio Aimi, Holger Moch, Peter Schraml, et al.
Plos One|March 11, 2009
Homogeneous MGMT immunoreactivity correlates with an unmethylated MGMT promoter status in brain metastases of various solid tumorsBarbara Ingold, Peter Schraml, Frank L Heppner, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 10, 2019
Specific immune cell and lymphatic vessel signatures identified by image analysis in renal cancerPeter Schraml, Maria Athelogou, Thomas Hermanns, et al.
Frontiers in Oncology|November 16, 2020
Liquid Biopsies in Renal Cell Carcinoma-Recent Advances and Promising New Technologies for the Early Detection of Metastatic DiseaseHarini Lakshminarayanan, Dorothea Rutishauser, Peter Schraml, et al.
Virchows Archiv : an International Journal of Pathology|September 26, 2012
Whole genome and transcriptome amplification: practicable tools for sustainable tissue biobanking?Adriana von Teichman, Martina Storz, Susanne Dettwiler, et al.
Experimental and Molecular Pathology|March 28, 2013
Onconeuronal antigen Cdr2 correlates with HIF prolyl-4-hydroxylase PHD1 and worse prognosis in renal cell carcinomaMuriel R Kaufmann, Peter Schraml, Thomas Hermanns, et al.
BMC Cancer|April 8, 2020
The DNA hypermethylation phenotype of colorectal cancer liver metastases resembles that of the primary colorectal cancersStephany Orjuela, Mirco Menigatti, Peter Schraml, et al.
Pageof 12

Showing results (1-10 of 113) with videos related to

Sort By:
Pageof 12
International Journal of Cancer|March 7, 2016
PD-L1 expression is regulated by hypoxia inducible factor in clear cell renal cell carcinomaMelanie Ruf, Holger Moch, Peter Schraml
Oncoimmunology|November 21, 2015
Interaction of tumor cells with infiltrating lymphocytes via CD70 and CD27 in clear cell renal cell carcinomaMelanie Ruf, Holger Moch, Peter Schraml
Histopathology|December 20, 2018
Clear cell renal cell carcinoma with wild-type von Hippel-Lindau gene: a non-existent or new tumour entity?Aashil A Batavia, Peter Schraml, Holger Moch
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 20, 2021
Cytoplasmic ADP-ribosylation levels correlate with markers of patient outcome in distinct human cancersFabio Aimi, Holger Moch, Peter Schraml, et al.
Plos One|March 11, 2009
Homogeneous MGMT immunoreactivity correlates with an unmethylated MGMT promoter status in brain metastases of various solid tumorsBarbara Ingold, Peter Schraml, Frank L Heppner, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 10, 2019
Specific immune cell and lymphatic vessel signatures identified by image analysis in renal cancerPeter Schraml, Maria Athelogou, Thomas Hermanns, et al.
Frontiers in Oncology|November 16, 2020
Liquid Biopsies in Renal Cell Carcinoma-Recent Advances and Promising New Technologies for the Early Detection of Metastatic DiseaseHarini Lakshminarayanan, Dorothea Rutishauser, Peter Schraml, et al.
Virchows Archiv : an International Journal of Pathology|September 26, 2012
Whole genome and transcriptome amplification: practicable tools for sustainable tissue biobanking?Adriana von Teichman, Martina Storz, Susanne Dettwiler, et al.
Experimental and Molecular Pathology|March 28, 2013
Onconeuronal antigen Cdr2 correlates with HIF prolyl-4-hydroxylase PHD1 and worse prognosis in renal cell carcinomaMuriel R Kaufmann, Peter Schraml, Thomas Hermanns, et al.
BMC Cancer|April 8, 2020
The DNA hypermethylation phenotype of colorectal cancer liver metastases resembles that of the primary colorectal cancersStephany Orjuela, Mirco Menigatti, Peter Schraml, et al.
Pageof 12